The efficacy of omega-3 supplements in prevention of preeclampsia among pregnant women with high risk factors in Sulaymaniyah governorate
Article Sidebar
Main Article Content
Abstract
Hypertensive disorders of pregnancy, including preeclampsia, complicate up to 10% of pregnancies worldwide, constituting one of the greatest causes of maternal and perinatal morbidity and mortality worldwide. The aim of the current study is to evaluate the efficacy of omega-3 supplements in prevention of preeclampsia among women with high risk. This study was carried out at Shanroy Hospital in al –Sulaimanya city from January 2016 till December 2016.In a single blind clinical trial, a total of 100 pregnant women were divided into two groups, one group had received omega-3 1000 mg and another group receive capsule prefilled with glucose as placebo.
Selection criteria include: primipara women, ages under than 20 and above 40 years, previous history of preeclampsia or positive family history, obesity, history of renal disease and hypertension. Demographic profile with pregnancy length and neonatal outcome were recorded. The result of this study showed there was significant difference in development of preeclampsia during current pregnancy between omega-3 and placebo groups and there was a significant relationship (p<0.05) between both groups when compare the preeclampsia in its all forms. In conclusion, omega-3 deems promising drug for prevention of preeclampsia in pregnant women with high risk.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Tikrit Journal of Pure Science is licensed under the Creative Commons Attribution 4.0 International License, which allows users to copy, create extracts, abstracts, and new works from the article, alter and revise the article, and make commercial use of the article (including reuse and/or resale of the article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made, and the licensor is not represented as endorsing the use made of the work. The authors hold the copyright for their published work on the Tikrit J. Pure Sci. website, while Tikrit J. Pure Sci. is responsible for appreciate citation of their work, which is released under CC-BY-4.0, enabling the unrestricted use, distribution, and reproduction of an article in any medium, provided that the original work is properly cited.
References
1-Robert JM, August PhA, Bakris G.Hypertension in pregnancy,1st ed.USA;American college of obstetricians and gynecology2013;Ch:1;13-14.
2-Van Dillen J,Mesman JA,Zwart JJ.Introducing maternal morbidity and it in the Netherlands. BJOG2010; 117:416-21.
3-Louise CK.Obstetrics by ten teachers,19ed. Great
Britain:Philip N Baker2011;Ch:10;120-121.
4- Oh R. Practical Application of fish oil (omega- 3fatty acids) in primary care . JABFP 2005; 18(1) :28-36.
5- Cleland GL, James JM , Proudman MS. The Role of fish oils in the treatment of Rheumatoid Arthritis. Drugs 2003; 36(9): 845-853.
6- Goldman DW, Pickett WC, Goetzl EJ. Human neutrophil Chemo tactic and degranlating activities of leukotriene B5 derived from EPA. Biochen Biophys Res Commun 1983; 117:282-8.
7-Coletta JM, Bell SJ, Roman AS.Omega-3 fatty acids and pregnancy. Rev Obstet Gynecol. 2010;3(4): 163-171.
8- Greenberg J A , Bell S J , Ausdal W V . Omega-3 Fatty Acid Supplementation During Pregnancy. Rev Obstet Gynecol.2008:1(4) 162- 167.
9- Schiff E, Ben-Baruch G, Barkai G. Reduction of thromboxane A2 synthesis in pregnancy by polyunsaturated fatty acid supplements. Am. J. Obstet. Gynecol. 1993:168(1):122-124.
10-Lalooha F, Ghaleh TD, Pakniiat H, Ranjkesh F, Gholshani T, Mashrabi O. Evaluation of the effect of omega-3 supplements in the prevention of preeclampsia among high risk women. African Journal of Pharmacy and Pharmacology 2012;6(35): 2580-2583.
11-Zhou SJ, Yalland L, McPhee AJ, Quinlivan J, Gibson RA, Makrides M. Fish-oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. Am J Clin Nutr 2012;95:1378–84.
12- Innis SM. Fatty acids and early human development. Early Hum Dev. 2007; 83(12):761-6.
13- Makrides M, Duley L, Olsen SF. Marine oil and other prostaglandin precursor, supplementation for pregnancy uncomplicated by preeclampsia or intrauterine growth restriction. Cochrane. Database. Syst Rev. 2006; 3:CD003402.
14-Dirix CE, Kester AD, Hornstra G. Associations between neonatal birth dimensions and maternal essential and trans fatty acid contents during pregnancy and at delivery. Br. J. Nutr. 2009; 101(3): 399-407.